Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG:

ProstAtak (aglatimagene besadenovec)

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Company:

Candel Therap

Drug class:

Gene transference, Thymidine kinase stimulant

Related drugs:

quaratusugene ozeplasmid (3)

retroviral expression vectors bearing inhibitory genes (0)

E7 TCR cells (0)

LPX EWS/FL1 T1 (0)

quaratusugene ozeplasmid (3)

retroviral expression vectors bearing inhibitory genes (0)

E7 TCR cells (0)

LPX EWS/FL1 T1 (0)

No biomarker	Non Small Cell Lung Cancer	No biomarker	Non Small Cell Lung Cancer	pembrolizumab + aglatimagene besadenovec Sensitive: B - Late Trials pembrolizumab + aglatimagene besadenovec Sensitive : B	pembrolizumab + aglatimagene besadenovec Sensitive: B - Late Trials pembrolizumab + aglatimagene besadenovec Sensitive : B
No biomarker	Pancreatic Ductal Adenocarcinoma	No biomarker	Pancreatic Ductal Adenocarcinoma	aglatimagene besadenovec Sensitive: B - Late Trials aglatimagene besadenovec Sensitive : B	aglatimagene besadenovec Sensitive: B - Late Trials aglatimagene besadenovec Sensitive : B
MGMT unmethylation	Glioma	MGMT unmethylation	Glioma	nivolumab + aglatimagene besadenovec Sensitive: C3 – Early Trials nivolumab + aglatimagene besadenovec Sensitive : C3	nivolumab + aglatimagene besadenovec Sensitive: C3 – Early Trials nivolumab + aglatimagene besadenovec Sensitive : C3
MGMT promoter methylation	Glioma	MGMT promoter methylation	Glioma	nivolumab + aglatimagene besadenovec Sensitive: C3 – Early Trials nivolumab + aglatimagene besadenovec Sensitive : C3	nivolumab + aglatimagene besadenovec Sensitive: C3 – Early Trials nivolumab + aglatimagene besadenovec Sensitive : C3
PD-L1 expression	Non Small Cell Lung Cancer	PD-L1 expression	Non Small Cell Lung Cancer	aglatimagene besadenovec Sensitive: C3 – Early Trials aglatimagene besadenovec Sensitive : C3	aglatimagene besadenovec Sensitive: C3 – Early Trials aglatimagene besadenovec Sensitive : C3
PD-L1 underexpression	Non Small Cell Lung Cancer	PD-L1 underexpression	Non Small Cell Lung Cancer	aglatimagene besadenovec Sensitive: C3 – Early Trials aglatimagene besadenovec Sensitive : C3	aglatimagene besadenovec Sensitive: C3 – Early Trials aglatimagene besadenovec Sensitive : C3